已授予合同
Managed Service for Blood Grouping Assays and Consumables
Gloucestershire Hospitals NHS Foundation Trust已就“Managed Service for Blood Grouping Assays and Consumables”授予此合同。
此招标已不再接受新的投标。 类似的进行中招标
用通俗的话说,这项招标是什么?
此公告尚未翻译,以原文语言显示。
同类招标的过往中标记录说明了什么?
- 半数同类合同的中标金额介于 £839,328 至 £1,820,106,中位数为 £1,142,000。
- CONSTELLIA LIMITED 在过去三年从该采购方取得 3 份同类合同。
根据过去 36 个月 19 项中标记录:相同工种、相同地区、金额相近。可信程度:中。以上仅反映过往情况,并非预测结果。 中标数据
谁赢得了这项招标,金额是多少?
- ORTHO-CLINICAL DIAGNOSTICS (trading as QuidelOrtho)赢得此合同,金额为£1,091,844,日期为2026年9月18日。
公告全文
原文(English)
Managed Service for Blood Grouping Assays and Consumables
Provision of automated blood transfusion analysers, associated reagents, consumables, maintenance and support services for Gloucestershire Hospitals NHS Foundation Trust.
This contract is being awarded via the NHSSC PCR 2015 Laboratory Diagnostics, Point of Care Testing & Pathology Managed Services OJEU REF - 2023/S 000-028831 Framework Agreement using the Direct Award mechanism.
The contract covers the supply, installation, validation, calibration, maintenance and ongoing support of automated transfusion analysers used by Gloucestershire Hospitals NHS Foundation Trust to perform blood grouping, antibody screening, further investigations and serological cross-matching. These functions are critical to the safe provision of blood and blood components for transfusion and support compliance with relevant regulatory and clinical standards.
The service includes the provision of analysers, reagents, consumables, quality control materials, software support and upgrades, preventative maintenance, technical support, fault resolution and user training. The supplier will also provide ongoing contract support, manage reagent supply in line with clinical activity, investigate analytical errors and equipment issues, and deliver agreed service levels and performance standards.
Automated testing and the electronic transfer of validated results are mandatory requirements for the Electronic Issue (EI) of blood. EI enables the rapid issue of compatible blood products, reducing blood wastage, improving stock management and supporting the timely treatment of patients across emergency departments, operating theatres, maternity services, critical care units, haematology services and other clinical areas.
The contract supports a Trust-wide critical clinical service for patients requiring transfusion, patients at risk of major blood loss, and antenatal patients and their babies. Continuity of analyser availability, reagent supply and technical support is essential to maintaining patient safety, regulatory compliance and operational resilience.
Any interruption to the service could adversely affect the Trust's ability to provide timely and safe transfusion support, potentially impacting emergency care, surgical procedures, maternity pathways and other critical patient services. The contract is therefore essential to ensuring the uninterrupted delivery of a safe, reliable and compliant transfusion service across Gloucestershire Hospitals NHS Foundation Trust
Estimated Annual Test Performed
• Blood Group 50,000
• Antibody Screen 50,000
• Antibody Panel 1,500
• Antibody Titre 15
• Crossmatch 1500
• RhK Phenotype 1000
• Other Phenotypes 180
• Direct Antiglobulin Test 650
通过邮件接收这些招标
每天一封邮件,列出你所选行业和地区的新招标。无需账户或密码。
快速解答
这项招标什么时候截止?
已于2026年9月22日截止。
这份合同价值多少?
采购方估计金额为£1,310,213。
采购方是谁?
采购方是Gloucestershire Hospitals NHS Foundation Trust。